Log In Sign up
The largest database of trusted experimental protocols

Anti phospho stat1 tyr701 9170

Manufactured by Cell Signaling Technology
Visit Supplier

Anti-phospho-STAT1 Tyr701 (9170) is a primary antibody that specifically recognizes STAT1 phosphorylated on tyrosine 701. This antibody is useful for detecting the activation of the STAT1 transcription factor.

Automatically generated - may contain errors

Lab products found in correlation

Doxorubicin and puromycin, by Merck Group (2 mentions) I bet151, by Bio-Techne (2 mentions) H3k4me1, by Abcam (2 mentions) Anti phospho stat1 ser727, by Cell Signaling Technology (2 mentions) Anti cdk19 hpa007053, by Merck Group (2 mentions) Anti phospho smad2 3 t220 t179 600 401 c48, by Rockland Immunochemicals (2 mentions) Anti cdk12 nb100 87012 and anti cdk13 nb100 68268, by Novus Biologicals (2 mentions) Anti cdk8 a302 501a and anti haspin, by Fortis Life Sciences (2 mentions) H3k4me3, by Fortis Life Sciences (2 mentions) Paclitaxel, by LC Laboratories (2 mentions) Tgf β1, by R&D Systems (2 mentions) H3k27ac, by Abcam (2 mentions)

Spelling variants of this product

STAT1 (305 citations) Anti-STAT1 (160 citations) Phospho-STAT1 (94 citations) Anti-phospho-STAT1 (54 citations) Phospho-STAT1 (Tyr701) (35 citations) Anti-phospho-STAT1 (Tyr701) (12 citations)

2 protocols using anti phospho stat1 tyr701 9170

1

Signaling pathway analysis protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compounds were stored under argon at –80 °C in 100% DMSO. Vehicle represents 0.1% DMSO unless otherwise specified. Sources: IFN-γ (PHC4031, Life Technologies), TGF-β1 (R&D Systems), paclitaxel (LC Laboratories), I-BET151 (Tocris), PMA (Calbiochem), and doxorubicin and puromycin (Sigma-Aldrich). Immunoblot antibodies: anti-FLAG (F1804), anti-Actin (A5060) and anti-CDK19 (HPA007053) from Sigma-Aldrich; anti-Smad2/3 (8685), anti-Smad2 pTail (3108), anti-STAT1 (9172), anti-phospho-STAT1 Tyr701 (9170) and anti-phospho-STAT1 Ser727 (9177), anti-CEBPA (2843), anti-ROCK1 (4035), anti-ROCK2 (9029), anti-CDK8 (4101), anti-caspase-3 (9662) anti-PARP (9532) and anti-CDK9 (2316) from Cell Signaling Technology (CST); anti-phospho-Smad2/3 T220/T179 (600-401-C48) from Rockland; anti-CDK12 (NB100-87012) and anti-CDK13 (NB100-68268) from Novus; and anti-CDK8 (A302-501A) and anti-Haspin (A302-241A) from Bethyl. ChIP antibodies: RNA pol II (Rpb1 N terminus, sc-899X lot B2713) from Santa Cruz; MED1 (A300-793A lot A300-793A-2), BRD4 (A301-985A lot A301-985A50-3), and CDK8 (A302-500A lot A302-500A-1) from Bethyl; and H3K4me3 (ab8580 lot 1308511), H3K27Ac (ab4729 lot GR104852-1), and H3K4me1 (ab8895 lot GR61306-1) from Abcam.
Pelish H.E., Liau B.B., Nitulescu I.I., Tangpeerachaikul A., Poss Z.C., Da Silva D.H., Caruso B.T., Arefolov A., Fadeyi O., Christie A.L., Du K., Banka D., Schneider E.V., Jestel A., Zou G., Si C., Ebmeier C.C., Bronson R.T., Krivtsov A.V., Myers A.G., Kohl N.E., Kung A.L., Armstrong S.A., Lemieux M.E., Taatjes D.J, & Shair M.D. (2015). Mediator Kinase Inhibition Further Activates Super-Enhancer Associated Genes in AML. Nature, 526(7572), 273-276.
+ Open protocol
+ Expand
2

Signaling pathway analysis protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compounds were stored under argon at –80 °C in 100% DMSO. Vehicle represents 0.1% DMSO unless otherwise specified. Sources: IFN-γ (PHC4031, Life Technologies), TGF-β1 (R&D Systems), paclitaxel (LC Laboratories), I-BET151 (Tocris), PMA (Calbiochem), and doxorubicin and puromycin (Sigma-Aldrich). Immunoblot antibodies: anti-FLAG (F1804), anti-Actin (A5060) and anti-CDK19 (HPA007053) from Sigma-Aldrich; anti-Smad2/3 (8685), anti-Smad2 pTail (3108), anti-STAT1 (9172), anti-phospho-STAT1 Tyr701 (9170) and anti-phospho-STAT1 Ser727 (9177), anti-CEBPA (2843), anti-ROCK1 (4035), anti-ROCK2 (9029), anti-CDK8 (4101), anti-caspase-3 (9662) anti-PARP (9532) and anti-CDK9 (2316) from Cell Signaling Technology (CST); anti-phospho-Smad2/3 T220/T179 (600-401-C48) from Rockland; anti-CDK12 (NB100-87012) and anti-CDK13 (NB100-68268) from Novus; and anti-CDK8 (A302-501A) and anti-Haspin (A302-241A) from Bethyl. ChIP antibodies: RNA pol II (Rpb1 N terminus, sc-899X lot B2713) from Santa Cruz; MED1 (A300-793A lot A300-793A-2), BRD4 (A301-985A lot A301-985A50-3), and CDK8 (A302-500A lot A302-500A-1) from Bethyl; and H3K4me3 (ab8580 lot 1308511), H3K27Ac (ab4729 lot GR104852-1), and H3K4me1 (ab8895 lot GR61306-1) from Abcam.
Pelish H.E., Liau B.B., Nitulescu I.I., Tangpeerachaikul A., Poss Z.C., Da Silva D.H., Caruso B.T., Arefolov A., Fadeyi O., Christie A.L., Du K., Banka D., Schneider E.V., Jestel A., Zou G., Si C., Ebmeier C.C., Bronson R.T., Krivtsov A.V., Myers A.G., Kohl N.E., Kung A.L., Armstrong S.A., Lemieux M.E., Taatjes D.J, & Shair M.D. (2015). Mediator Kinase Inhibition Further Activates Super-Enhancer Associated Genes in AML. Nature, 526(7572), 273-276.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!